SC Moatti of Mighty Capital joins Nick to discuss Creating Powerful Networks, 3 Rules for Great Product, and the Future of Mobile Tech. In this episode, we cover:Backstory/ Path to becoming involved in venture? What led you to start Mighty Capital? Talk more about Products that Count, what was the…
On this special segment of The Full Ratchet, the following investors are featured: Brendan Wallace Bilal Zuberi Joe Medved Each investor highlights a situation where they decided not to invest, why they passed, and how it played out.
John Fein of Firebrand Ventures joins Nick to discuss, From Operator to Accelerator MD to Fund Manager. In this episode, we cover: So you participated in 5 startups, after which you scaled an organization from zero to 1,500 employees and $2B/year in revenue. Talk about your background and experience at…
On this special segment of The Full Ratchet, the following investors are featured: Paul Martino Evangelos Simoudis Ben Narasin Each investor discusses a portfolio company that did not survive and why it failed.
Roy Bahat of Bloomberg Beta joins Nick to discuss VCs Ride the Bus, Comeback Cities & Unorthodox Investing. In this episode, we cover: Backstory / Path to Bloomberg Beta Bloomberg Beta has taken a self-described “unorthodox approach”– Tell us about your approach and why it’s unique. I was exploring your…
On this special segment of The Full Ratchet, the following investors are featured: Tim O’Reilly Sarah Anderson Vic Pascucci Each investor describes the most unusual situation or pitch that they’ve encountered as an investor.
Bradley Tusk of Tusk Ventures joins Nick to discuss Corruption, Extortion and the Fight Against Entrenched Interests– How a VC Saves Startups from Death by Politics. In this episode, we cover: Why and how did you get into VC? You have a nice model where you generate revenue through Tusk…
On this special segment of The Full Ratchet, the following investors are featured: David Cohen Ben Einstein Jordan Nof Each investor illustrates a critical lesson learned about startup investing and how it’s changed their approach.
Jim Tananbaum of Foresite Capital joins Nick to discuss Growth Investing in Biotech, Genomics and Pharma. In this episode, we cover: His 25 years in the industry working as both an entrepreneur and investor.. often at the same time Jim’s investment focus at Foresite The major changes in biotech over…
On this special segment of The Full Ratchet, the following investors are featured: Brian Ascher Joe Medved Ash Fontana Each investor discusses sectors, drivers and/or trends that may have significant impact in the future and are potentially positioned for outsized-returns.